Cargando…

Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β

[Image: see text] We disclose a novel class of 6-amino-tetrahydroquinazoline derivatives that inhibit human topoisomerase II (topoII), a validated target of anticancer drugs. In contrast to topoII-targeted drugs currently in clinical use, these compounds do not act as topoII poisons that enhance enz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortega, Jose Antonio, Arencibia, Jose M., Minniti, Elirosa, Byl, Jo Ann W., Franco-Ulloa, Sebastian, Borgogno, Marco, Genna, Vito, Summa, Maria, Bertozzi, Sine Mandrup, Bertorelli, Rosalia, Armirotti, Andrea, Minarini, Anna, Sissi, Claudia, Osheroff, Neil, De Vivo, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668297/ https://www.ncbi.nlm.nih.gov/pubmed/33079544 http://dx.doi.org/10.1021/acs.jmedchem.0c00774

Ejemplares similares

Design, Synthesis, Dynamic Docking, Biochemical Characterization, and in Vivo Pharmacokinetics Studies of Novel Topoisomerase II Poisons with Promising Antiproliferative Activity
por: Arencibia, Jose M., et al.
Publicado: (2020)

Design, Synthesis, In Vitro and In Vivo Characterization of Selective NKCC1 Inhibitors for the Treatment of Core Symptoms in Down Syndrome
por: Borgogno, Marco, et al.
Publicado: (2021)

Design, Synthesis, In Vitro and In Vivo Characterization of CDC42 GTPase Interaction Inhibitors for the Treatment of Cancer
por: Brindani, Nicoletta, et al.
Publicado: (2023)

Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders
por: Savardi, Annalisa, et al.
Publicado: (2020)

Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer
por: Jahid, Sohail, et al.
Publicado: (2022)

Smoothed Potential MD Simulations for Dissociation Kinetics of Etoposide To Unravel Isoform Specificity in Targeting Human Topoisomerase II
por: Kuriappan, Jissy A., et al.
Publicado: (2019)

Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance
por: Colini Baldeschi, Arianna, et al.
Publicado: (2022)

Etoposide Quinone Is a Covalent Poison of Human Topoisomerase IIβ
por: Smith, Nicholas A., et al.
Publicado: (2014)

Topoisomerase II Is Crucial for Fork Convergence during Vertebrate Replication Termination
por: Heintzman, Darren R., et al.
Publicado: (2019)

Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors
por: Caputo, Samantha, et al.
Publicado: (2020)

Actions of a Novel Bacterial Topoisomerase Inhibitor against Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enhancement of Double-Stranded DNA Breaks
por: Dauda, Soziema E., et al.
Publicado: (2023)

Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta
por: Liessi, Nara, et al.
Publicado: (2020)

Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent N-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA) Inhibitors for Oral Administration
por: Di Fruscia, Paolo, et al.
Publicado: (2021)

Natural Products as Topoisomerase II Poisons: Effects of Thymoquinone on DNA Cleavage Mediated by Human Topoisomerase IIα
por: Ashley, Rachel E., et al.
Publicado: (2014)

Voreloxin Is an Anticancer Quinolone Derivative that Intercalates DNA and Poisons Topoisomerase II
por: Hawtin, Rachael E., et al.
Publicado: (2010)

Direct Monitoring of the Strand Passage Reaction of DNA Topoisomerase II Triggers Checkpoint Activation
por: Furniss, Katherine L., et al.
Publicado: (2013)

Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site
por: Franco-Ulloa, Sebastian, et al.
Publicado: (2018)

Analysis of the uncharted, druglike property space by self-organizing maps
por: Takács, Gergely, et al.
Publicado: (2021)

The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing
por: Deweese, Joseph E., et al.
Publicado: (2009)

Interlinked DNA nano-circles for measuring topoisomerase II activity at the level of single decatenation events
por: Kristoffersen, Emil L., et al.
Publicado: (2017)

No Time to Relax and Unwind: Exploration of Topoisomerases and a Growing Field of Study
por: Deweese, Joseph E., et al.
Publicado: (2023)

QEX: target-specific druglikeness filter enhances ligand-based virtual screening
por: Mochizuki, Masahiro, et al.
Publicado: (2018)

Description of Druglike Properties of Safranal and Its Chemistry behind Low Oral Exposure
por: Dogra, Ashish, et al.
Publicado: (2020)

Bioactive Coumarins and Xanthones From Calophyllum Genus and Analysis of Their Druglikeness and Toxicological Properties
por: Gómez-Verjan, J.C., et al.
Publicado: (2017)

Effects of magnesium and related divalent metal ions in topoisomerase structure and function
por: Sissi, Claudia, et al.
Publicado: (2009)

Uniting Cheminformatics and Chemical Theory To Predict the Intrinsic Aqueous Solubility of Crystalline Druglike Molecules
por: McDonagh, James L., et al.
Publicado: (2014)

Iterative Conversion of Cyclin Binding Groove Peptides into Druglike CDK Inhibitors with Antitumor Activity
por: Premnath, Padmavathy Nandha, et al.
Publicado: (2014)

An In Silico Approach towards the Prediction of Druglikeness Properties of Inhibitors of Plasminogen Activator Inhibitor1
por: Subramanian, Umadevi, et al.
Publicado: (2014)

Discovery of Potent and Selective Tricyclic Inhibitors of Bruton’s Tyrosine Kinase with Improved Druglike Properties
por: Wang, Xiaojing, et al.
Publicado: (2017)

Evaluating Translational Efficiency of Noncanonical Amino Acids to Inform the Design of Druglike Peptide Libraries
por: Chan, Alix I, et al.
Publicado: (2023)

Identification, Structure–Activity Relationship, and Biological Characterization of 2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indoles as a Novel Class of CFTR Potentiators
por: Brindani, Nicoletta, et al.
Publicado: (2020)

1,3-Dibenzyl-1,2,3,4-tetrahydroquinazoline-2,4-dione
por: Karimova, Gavhar, et al.
Publicado: (2010)

A Novel Ambroxol-Derived Tetrahydroquinazoline with a Potency against SARS-CoV-2 Proteins
por: Krysantieva, Alena I., et al.
Publicado: (2023)

Self-Adhesive and Antioxidant Poly(vinylpyrrolidone)/Alginate-Based Bilayer Films Loaded with Malva sylvestris Extracts as Potential Skin Dressings
por: Contardi, Marco, et al.
Publicado: (2022)

Synthesis of Dihydrouracils Spiro-Fused to Pyrrolidines: Druglike Molecules Based on the 2-Arylethyl Amine Scaffold
por: Blanco-Ania, Daniel, et al.
Publicado: (2010)

The Allosteric Site on SHP2’s Protein Tyrosine Phosphatase Domain is Targetable with Druglike Small Molecules
por: Marsh-Armstrong, Brennan, et al.
Publicado: (2018)

Structure-Guide Design and Optimization of Potential Druglikeness Inhibitors for TGFβRI with the Pyrrolopyrimidine Scaffold
por: Meng, Dan, et al.
Publicado: (2022)

miDruglikeness: Subdivisional Drug-Likeness Prediction Models Using Active Ensemble Learning Strategies
por: Cai, Chenjing, et al.
Publicado: (2022)

Hybrid Approach to Identifying Druglikeness Leading Compounds against COVID-19 3CL Protease
por: Aqeel, Imra, et al.
Publicado: (2022)

Telling Your Right Hand from Your Left: The Effects of DNA Supercoil Handedness on the Actions of Type II Topoisomerases
por: Jian, Jeffrey Y., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7ef473rst3rujlmd29qgedgocl